13F-HR filed by BIOS Capital Management, LP
BIOS Capital Management, LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 6 holding rows worth $82,622,742.
- Accession
- 0001813845-26-000002
- Filer
- CIK 1813845
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 9 entries on the cover page, a total value of $82,622,742 stated on the cover page (in dollars after the unit check, H1), rows summing to $82,622,742 with VALUE read as dollars as filed, 13F file number 028-24868. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSteelhead Capital Management, LLC028-24869
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS INC | 005083100 | COM | 10,049,996 | $61,505,976 | dollars as filed | |
| COGNITION THERAPEUTICS INC | 19243B102 | COM | 6,000,000 | $8,100,001 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 3,683,429 | $7,403,692 | dollars as filed | |
| LANTERN PHARMA INC | 51654W101 | COM | 1,009,507 | $3,058,806 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 1,690,751 | $1,961,271 | dollars as filed | |
| IN8BIO INC | 45674E208 | COM NEW | 253,417 | $592,996 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001813845-26-000002 | this filing | 2026-02-13 | acceptance time not in the bulk data set |